223 related articles for article (PubMed ID: 31364863)
1. Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review.
Fayand A; Boutboul D; Galicier L; Kahn JE; Buob D; Boffa JJ; Cez A; Oksenhendler E; Grateau G; Ducharme-Bénard S; Georgin-Lavialle S
Amyloid; 2019 Dec; 26(4):197-202. PubMed ID: 31364863
[No Abstract] [Full Text] [Related]
2. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.
Sopfe J; Endres A; Campbell K; Hayes K; Trout AT; Liang X; Lorsbach R; O'Brien MM; Cost CR
Pediatr Blood Cancer; 2019 May; 66(5):e27613. PubMed ID: 30680887
[TBL] [Abstract][Full Text] [Related]
3. The French paediatric cohort of Castleman disease: a retrospective report of 23 patients.
Borocco C; Ballot-Schmit C; Ackermann O; Aladjidi N; Delaleu J; Giacobbi-Milet V; Jannier S; Jeziorski E; Maurier F; Perel Y; Piguet C; Oksenhendler E; Koné-Paut I; Galeotti C
Orphanet J Rare Dis; 2020 Apr; 15(1):95. PubMed ID: 32303241
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
Nagy A; Bhaduri A; Shahmarvand N; Shahryari J; Zehnder JL; Warnke RA; Mughal T; Ali S; Ohgami RS
Blood Adv; 2018 Mar; 2(5):481-491. PubMed ID: 29496669
[TBL] [Abstract][Full Text] [Related]
5. Castleman Disease: A Multicenter Case Series from Turkey.
Gündüz E; Kırkızlar HO; Ümit EG; Karaman Gülsaran S; Özkocaman V; Özkalemkaş F; Candar Ö; Elverdi T; Küçükyurt S; Paydaş S; Çeneli Ö; Karakuş S; Maral S; Ekinci Ö; İpek Y; Kis C; Güven ZT; Akdeniz A; Celkan T; Eroğlu Küçükdiler AH; Akgün Çağlıyan G; Özçelik Şengöz C; Karataş A; Bulduk T; Özcan A; Belen Apak FB; Canbolat A; Kartal İ; Ören H; Töret E; Özdemir GN; Bakanay Öztürk ŞM
Turk J Haematol; 2022 Jun; 39(2):130-135. PubMed ID: 35176839
[TBL] [Abstract][Full Text] [Related]
6. Unicentric Castleman disease: A case report of an atypical presentation and successful management.
Muhammad T; Alkheder A; Mazloum A; Almooay A; Naziha L; Shaheen M
Int J Surg Case Rep; 2024 May; 118():109688. PubMed ID: 38669805
[TBL] [Abstract][Full Text] [Related]
7. Overview of Castleman disease.
Dispenzieri A; Fajgenbaum DC
Blood; 2020 Apr; 135(16):1353-1364. PubMed ID: 32106302
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China.
Hu S; Li Z; Wang H; Chen L; Ma Y; Zhu X; Li J; Dong R; Yao W; Dong C; Zhang H; Li K; Dong K; Zhai X
Eur J Pediatr; 2023 Dec; 182(12):5519-5530. PubMed ID: 37782352
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of 65 patients with Castleman disease in a single center in China.
Wang XQ; Zhong NN; Sun Q; Yan SC; Xu GC; Wang YG; Peng LW; Liu B; Bu LL
Sci Rep; 2022 May; 12(1):8694. PubMed ID: 35610300
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review.
Wojtyś M; Piekarska A; Kunc M; Ptaszyński K; Biernat W; Zaucha JM; Waloszczyk P; Lisowski P; Kubisa B; Grodzki T
J Thorac Dis; 2019 Nov; 11(11):4859-4874. PubMed ID: 31903277
[TBL] [Abstract][Full Text] [Related]
11. AA amyloidosis associated with Castleman disease: A case report and review of the literature.
Bernabei L; Waxman A; Caponetti G; Fajgenbaum DC; Weiss BM
Medicine (Baltimore); 2020 Feb; 99(6):e18978. PubMed ID: 32028407
[TBL] [Abstract][Full Text] [Related]
12. Castleman disease: A single-center case series.
Pribyl K; Vakayil V; Farooqi N; Arora N; Kreitz B; Ikramuddin S; Linden MA; Harmon J
Int J Surg Case Rep; 2021 Mar; 80():105650. PubMed ID: 33631648
[TBL] [Abstract][Full Text] [Related]
13. A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease.
Koga T; Sumiyoshi R; Kawakami A; Yoshizaki K
Mod Rheumatol; 2019 Mar; 29(2):302-305. PubMed ID: 30285516
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 30 cases of Castleman disease with different types of thoracic involvement].
Zhang XX; Jiang L; Wang CY; Gu YY; Li LG; Xia TT; Huang Y; Huang PK; Zhang QL
Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):149-156. PubMed ID: 32135633
[No Abstract] [Full Text] [Related]
15. Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.
Zhang X; Rao H; Xu X; Li Z; Liao B; Wu H; Li M; Tong X; Li J; Cai Q
Cancer Sci; 2018 Jan; 109(1):199-206. PubMed ID: 29124835
[TBL] [Abstract][Full Text] [Related]
16. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
Li P; Liu H; Li H; Li A; Yu G; Yin W
Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome and unique cytokine microenvironment of Castleman disease.
Wing A; Xu J; Meng W; Rosenfeld AM; Li EY; Wertheim G; Paessler M; Bagg A; Frank D; Tan K; Teachey DT; Lim MS; Prak EL; Fajgenbaum DC; Pillai V
Mod Pathol; 2022 Apr; 35(4):451-461. PubMed ID: 34686774
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of Castleman disease.
Soumerai JD; Sohani AR; Abramson JS
Cancer Control; 2014 Oct; 21(4):266-78. PubMed ID: 25310208
[TBL] [Abstract][Full Text] [Related]
19. Clinical, laboratory and imaging findings in Castleman's disease - The subtype decides.
Haap M; Wiefels J; Horger M; Hoyer A; Müssig K
Blood Rev; 2018 May; 32(3):225-234. PubMed ID: 29223447
[TBL] [Abstract][Full Text] [Related]
20. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
van Rhee F; Oksenhendler E; Srkalovic G; Voorhees P; Lim M; Dispenzieri A; Ide M; Parente S; Schey S; Streetly M; Wong R; Wu D; Maillard I; Brandstadter J; Munshi N; Bowne W; Elenitoba-Johnson KS; Fössa A; Lechowicz MJ; Chandrakasan S; Pierson SK; Greenway A; Nasta S; Yoshizaki K; Kurzrock R; Uldrick TS; Casper C; Chadburn A; Fajgenbaum DC
Blood Adv; 2020 Dec; 4(23):6039-6050. PubMed ID: 33284946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
